The Scottish Medicines Consortium (SMC) provides advice to NHS boards in Scotland about newly licensed medicines and new indications of established products following submissions from pharmaceutical companies. The SMC will only consider new treatments within their licensed indication once they have been granted a marketing authorisation (licence). Manufacturers can seek a marketing authorisation for new drugs and indications from either the European Medicines Agency or Medicines and Healthcare Products Regulatory Agency. 

Our research showed that people in Scotland were already accessing PrEP through online generic providers or by purchasing it at private clinics. Both these methods of access present their own challenges, including that people may have little or no guidance on drug regimens or potential side effects, that they might use PrEP incorrectly and not receive regular HIV and STI checks. With growing community demand for PrEP we undertook a range of activities to ensure that people using PrEP had the support they needed to do so safely, and that those most at risk of HIV could access PrEP via our subsidised healthcare system.

This poster was presented at AIDS 2016 Conference in Durban, South Africa.

Download Poster